freenet AG (OTCMKTS:FRTAF – Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 29,900 shares, a growth of 7.2% from the August 31st total of 27,900 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 299.0 days.
freenet Stock Performance
OTCMKTS:FRTAF opened at $26.87 on Wednesday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.62 and a current ratio of 0.67. freenet has a fifty-two week low of $26.87 and a fifty-two week high of $26.87. The company has a 50 day simple moving average of $26.98 and a two-hundred day simple moving average of $27.08. The company has a market capitalization of $3.44 billion, a PE ratio of 14.52 and a beta of 0.40.
freenet (OTCMKTS:FRTAF – Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.69 earnings per share for the quarter. The company had revenue of $651.55 million during the quarter. freenet had a net margin of 8.56% and a return on equity of 18.16%.
freenet Company Profile
freenet AG provides telecommunications, broadcasting, and multimedia services for mobile communications/mobile internet, and digital lifestyle sectors in Germany. It operates through Mobile Communications, TV and Media, and Other/Holding segments. The Mobile Communications segment engages in the marketing of mobile communications services, which include voice and data services from the mobile network operators; planning, set up, installation, and maintenance services for WiFi networks; and selling and distribution of mobile devices, as well as offers additional services for mobile data communications and digital lifestyle.
See Also
- Five stocks we like better than freenet
- What Does Downgrade Mean in Investing?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is the S&P/TSX Index?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Why is the Ex-Dividend Date Significant to Investors?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for freenet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for freenet and related companies with MarketBeat.com's FREE daily email newsletter.